Ciferská H - Search Results

1

Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study.

Závada J, Uher M, Svobodová R, Olejárová M, Hušáková M, Ciferská H, Hulejová H, Tomčík M, Šenolt L, Vencovský J. Závada J, et al. Among authors: ciferska h. Arthritis Res Ther. 2015 Nov 25;17:341. doi: 10.1186/s13075-015-0862-4. Arthritis Res Ther. 2015. PMID: 26608564 Free PMC article.

2

VEXAS syndrome: a report of three cases.

Ciferska H, Gregová M, Klein M, Šenolt L, Soukupová Maaloufová J, Pavelka K, Mann H. Ciferska H, et al. Clin Exp Rheumatol. 2022 Jul;40(7):1449. doi: 10.55563/clinexprheumatol/3z07e9. Epub 2022 Feb 12. Clin Exp Rheumatol. 2022. PMID: 35238760 Free article. No abstract available.

3

The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic value.

Ciferská H, Horák P, Hermanová Z, Ordeltová M, Zadrazil J, Tichý T, Scudla V. Ciferská H, et al. Clin Rheumatol. 2007 May;26(5):723-8. doi: 10.1007/s10067-006-0389-9. Epub 2006 Nov 14. Clin Rheumatol. 2007. PMID: 17103120

4

C1q complement component and -antibodies reflect SLE activity and kidney involvement.

Horák P, Hermanová Z, Zadrazil J, Ciferská H, Ordeltová M, Kusá L, Zurek M, Tichý T. Horák P, et al. Among authors: ciferska h. Clin Rheumatol. 2006 Jul;25(4):532-6. doi: 10.1007/s10067-005-0110-4. Epub 2005 Nov 26. Clin Rheumatol. 2006. PMID: 16311713

5

Expression of nucleic acid binding Toll-like receptors in control, lupus and transplanted kidneys--a preliminary pilot study.

Ciferska H, Horak P, Konttinen YT, Krejci K, Tichy T, Hermanova Z, Zadrazil J. Ciferska H, et al. Lupus. 2008 Jun;17(6):580-5. doi: 10.1177/0961203307088130. Lupus. 2008. PMID: 18539713

6

Protocol biopsy of a transplanted kidney as a tool for monitoring adequacy of immunosuppressive therapy: 10 years of experience from a single transplant center.

Krejčí K, Tichý T, Al-Gabri S, Horák P, Ciferská H, Hrubý M, Horčička V Jr, Strebl P, Zamboch K, Bachleda P, Zadrazil J. Krejčí K, et al. Among authors: ciferska h. Transplant Proc. 2011 Jun;43(5):1576-82. doi: 10.1016/j.transproceed.2011.03.008. Transplant Proc. 2011. PMID: 21693237

7

The Examination of a TPMT Gene Before Administration of Azathioprine in Rheumatology Practice and Identification of a Novel Variant p.W29R.

Pavelcova K, Hanova P, Ciferska H, Hasikova L, Stiburkova B. Pavelcova K, et al. Among authors: ciferska h. J Clin Rheumatol. 2022 Mar 1;28(2):e363-e367. doi: 10.1097/RHU.0000000000001727. J Clin Rheumatol. 2022. PMID: 34870401

8

Complement system in SLE as a target for antibodies.

Horak P, Skacelova M, Zadrazil J, Smrzova A, Krejcí K, Ciferska H, Hermanova Z. Horak P, et al. Among authors: ciferska h. Curr Rheumatol Rev. 2013;9(1):34-44. doi: 10.2174/1573397111309010009. Curr Rheumatol Rev. 2013. PMID: 25198366

9

Trial of Anifrolumab in Active Systemic Lupus Erythematosus.

Morand EF, Furie R, Tanaka Y, Bruce IN, Askanase AD, Richez C, Bae SC, Brohawn PZ, Pineda L, Berglind A, Tummala R; TULIP-2 Trial Investigators. Morand EF, et al. N Engl J Med. 2020 Jan 16;382(3):211-221. doi: 10.1056/NEJMoa1912196. Epub 2019 Dec 18. N Engl J Med. 2020. PMID: 31851795 Clinical Trial.

10

The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic value.

Ciferská H, Horák P, Heřmanová Z, Ordeltová M, Zadražil J, Tichý T, Ščudla V. Ciferská H, et al. Clin Rheumatol. 2007 May;26(5):852. doi: 10.1007/s10067-007-0571-8. Clin Rheumatol. 2007. PMID: 27520703 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page